| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 144, Issue 10 3877-3880, Copyright © 1990 by American Association of Immunologists
ARTICLES |
JE Albina, CD Mills, WL Henry Jr and MD Caldwell
Department of Surgery, Rhode Island Hospital, Providence 02903.
Arginine can be metabolized by inflammatory cells through at least two pathways. One is an oxidative l-arginine deiminase (OAD) that results in the formation of citrulline and reactive nitrogen intermediates. The other is arginase, which determines the production of ornithine and urea. The temporal expression of these pathways in an experimental wound model (s.c. implanted polyvinyl alcohol sponges in the rat) was investigated by examining the concentrations of amino acids and of nitrite in fluids obtained from the sponges 6 h to 15 day after implantation. These analyses revealed two distinct periods during which the arginine concentration in the fluids was markedly below plasma levels. During the early period (less than 3 days after sponge implantation) wound fluid contained more citrulline and nitrite than at any other time, suggesting OAD activity. In contrast, ornithine accumulated in the fluids during the late decrease in arginine concentration that extended beyond day 3, during which time the wound fluid also contained a high arginase activity. This time-dependent expression of different pathways of arginine metabolism in wounds was confirmed in sponge cultures containing [guanido-14C]-l-arginine. Cells contained in sponges harvested less than 48 h after implantation metabolized labeled arginine mainly to labeled citrulline, whereas labeled urea was produced during culture of sponges harvested after this time. The low arginine content of wound fluid did not appear to be rate limiting for the expression of OAD in late sponges because no OAD activity was evidenced when 4 mM arginine was added to the cultures. These results indicate that the OAD pathway is expressed in this model predominantly during the early, polymorphonuclear leukocyte- predominant, phase of repair. At this time, the reactive nitrogen intermediates resulting from the metabolism of arginine may mediate some of the events characteristic of early inflammation, including microbiostasis, vasodilation, and inhibition/reversal of platelet aggregation. In turn, the late suppression of this pathway and the catabolism of arginine through arginase may promote macrophage function within wounds.
This article has been cited by other articles:
|
|
 |
|
  S. M. Morris Jr. Arginine Metabolism: Boundaries of Our Knowledge J. Nutr., June 1, 2007; 137(6): 1602S - 1609S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Jacobsen, K. Theilgaard-Monch, E. I. Christensen, and N. Borregaard Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils Blood, April 1, 2007; 109(7): 3084 - 3087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Edwards, X. Zhang, K. A. Frauwirth, and D. M. Mosser Biochemical and functional characterization of three activated macrophage populations J. Leukoc. Biol., December 1, 2006; 80(6): 1298 - 1307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Schulz and J. Stechmiller Wound healing and nitric oxide production: too little or too much may impair healing and cause chronic wounds. International Journal of Lower Extremity Wounds, March 1, 2006; 5(1): 6 - 8. [PDF]
|
|
|
|
 |
|
 C. Murdoch, M. Muthana, and C. E. Lewis Hypoxia Regulates Macrophage Functions in Inflammation J. Immunol., November 15, 2005; 175(10): 6257 - 6263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Stechmiller, B. Langkamp-Henken, B. Childress, K. A. Herrlinger-Garcia, J. Hudgens, L. Tian, S. S. Percival, and R. Steely Arginine Supplementation Does Not Enhance Serum Nitric Oxide Levels in Elderly Nursing Home Residents With Pressure Ulcers Biol Res Nurs, April 1, 2005; 6(4): 289 - 299. [Abstract] [PDF]
|
|
|
|
 |
|
 A. J. Cardounel, Y. Xia, and J. L. Zweier Endogenous Methylarginines Modulate Superoxide as Well as Nitric Oxide Generation from Neuronal Nitric-oxide Synthase: DIFFERENCES IN THE EFFECTS OF MONOMETHYL- AND DIMETHYLARGININES IN THE PRESENCE AND ABSENCE OF TETRAHYDROBIOPTERIN J. Biol. Chem., March 4, 2005; 280(9): 7540 - 7549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Stechmiller, B. Childress, and L. Cowan Arginine Supplementation and Wound Healing Nutr Clin Pract, February 1, 2005; 20(1): 52 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Correa, M. C. Rodriguez-Galan, B. Salido-Renteria, R. Cano, H. Cejas, and C. E. Sotomayor High dissemination and hepatotoxicity in rats infected with Candida albicans after stress exposure: potential sensitization to liver damage Int. Immunol., December 1, 2004; 16(12): 1761 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Feezor, H. N. Paddock, H. V. Baker, J. C. Varela, J. Barreda, L. L. Moldawer, G. S. Schultz, and D. W. Mozingo Temporal patterns of gene expression in murine cutaneous burn wound healing Physiol Genomics, February 13, 2004; 16(3): 341 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Stechmiller, B. Childress, and T. Porter Arginine Immunonutrition in Critically Ill Patients: A Clinical Dilemma Am. J. Crit. Care., January 1, 2004; 13(1): 17 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, J. A. Van Ginderachter, L. Brys, P. De Baetselier, G. Raes, and A. B. Geldhof Nitric Oxide-Independent CTL Suppression during Tumor Progression: Association with Arginase-Producing (M2) Myeloid Cells J. Immunol., May 15, 2003; 170(10): 5064 - 5074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bruch-Gerharz, O. Schnorr, C. Suschek, K.-F. Beck, J. Pfeilschifter, T. Ruzicka, and V. Kolb-Bachofen Arginase 1 Overexpression in Psoriasis: Limitation of Inducible Nitric Oxide Synthase Activity as a Molecular Mechanism for Keratinocyte Hyperproliferation Am. J. Pathol., January 1, 2003; 162(1): 203 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Rodriguez-Galan, C. Sotomayor, M. E. Costamagna, A. M. Cabanillas, B. S. Renteria, A. M. Masini-Repiso, and S. Correa Immunocompetence of macrophages in rats exposed to Candida albicans infection and stress Am J Physiol Cell Physiol, January 1, 2003; 284(1): C111 - C118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. B. Childress and J. K. Stechmiller Role of Nitric Oxide in Wound Healing Biol Res Nurs, July 1, 2002; 4(1): 5 - 15. [Abstract] [PDF]
|
|
|
|
|
|
M. Hesse, M. Modolell, A. C. La Flamme, M. Schito, J. M. Fuentes, A. W. Cheever, E. J. Pearce, and T. A. Wynn Differential Regulation of Nitric Oxide Synthase-2 and Arginase-1 by Type 1/Type 2 Cytokines In Vivo: Granulomatous Pathology Is Shaped by the Pattern of L-Arginine Metabolism J. Immunol., December 1, 2001; 167(11): 6533 - 6544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-I Chang, J. C. Liao, and L. Kuo Macrophage Arginase Promotes Tumor Cell Growth and Suppresses Nitric Oxide-mediated Tumor Cytotoxicity Cancer Res., February 1, 2001; 61(3): 1100 - 1106. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Kepka-Lenhart, S. K. Mistry, G. Wu, and S. M. Morris Jr. Arginase I: a limiting factor for nitric oxide and polyamine synthesis by activated macrophages? Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2237 - R2242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. ISHIZUKA, R. CUNARD, S. POUCELL-HATTON, L. WEAD, M. LORTIE, S. C. THOMSON, F. B. GABBAI, J. SATRIANO, and R. C. BLANTZ Agmatine Inhibits Cell Proliferation and Improves Renal Function in Anti--Thy-1 Glomerulonephritis J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2256 - 2264. [Abstract] [Full Text]
|
|
|
|
|
|
C. D. Mills, K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill M-1/M-2 Macrophages and the Th1/Th2 Paradigm J. Immunol., June 15, 2000; 164(12): 6166 - 6173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ketteler, R. Westenfeld, A. Gawlik, E. de Heer, and A. Distler Acute glomerular upregulation of ornithine decarboxylase is not essential for mesangial cell proliferation and matrix expansion in anti-Thy-1-nephritis Nephrol. Dial. Transplant., January 1, 2000; 15(1): 16 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. FRANK, B. STALLMEYER, H. KÄMPFER, N. KOLB, and J. PFEILSCHIFTER Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair FASEB J, November 1, 1999; 13(14): 2002 - 2014. [Abstract] [Full Text]
|
|
|
|
|
|
M. Munder, K. Eichmann, J. M. Moran, F. Centeno, G. Soler, and M. Modolell Th1/Th2-Regulated Expression of Arginase Isoforms in Murine Macrophages and Dendritic Cells J. Immunol., October 1, 1999; 163(7): 3771 - 3777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Lee, A. N. Salyapongse, G. A. Bragdon, L. L. Shears II, S. C. Watkins, H. D. J. Edington, and T. R. Billiar Impaired wound healing and angiogenesis in eNOS-deficient mice Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1600 - H1608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J Andrew and B. Mayer Enzymatic function of nitric oxide synthases Cardiovasc Res, August 15, 1999; 43(3): 521 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Salimuddin, A. Nagasaki, T. Gotoh, H. Isobe, and M. Mori Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide Am J Physiol Endocrinol Metab, July 1, 1999; 277(1): E110 - E117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Satriano, S. Ishizuka, D. C. Archer, R. C. Blantz, and C. J. Kelly Regulation of intracellular polyamine biosynthesis and transport by NO and cytokines TNF-alpha and IFN-gamma Am J Physiol Cell Physiol, April 1, 1999; 276(4): C892 - C899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Reichner, A. J. Meszaros, C. A. Louis, W. L. Henry Jr., B. Mastrofrancesco, B.-A. Martin, and J. E. Albina Molecular and Metabolic Evidence for the Restricted Expression of Inducible Nitric Oxide Synthase in Healing Wounds Am. J. Pathol., April 1, 1999; 154(4): 1097 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Angele, M. G. Schwacha, N. Smail, R. A. Catania, A. Ayala, W. G. Cioffi, and I. H. Chaudry Hypoxemia in the absence of blood loss upregulates iNOS expression and activity in macrophages Am J Physiol Cell Physiol, February 1, 1999; 276(2): C285 - C290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Angele, N. Smail, M. W. Knoferl, A. Ayala, W. G. Cioffi, and I. H. Chaudry L-Arginine restores splenocyte functions after trauma and hemorrhage potentially by improving splenic blood flow Am J Physiol Cell Physiol, January 1, 1999; 276(1): C145 - C151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Que, S. P. Kantrow, C. P. Jenkinson, C. A. Piantadosi, and Y.-C. T. Huang Induction of arginase isoforms in the lung during hyperoxia Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L96 - L102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Louis, J. S. Reichner, W. L. Henry Jr., B. Mastrofrancesco, T. Gotoh, M. Mori, and J. E. Albina Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R775 - R782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Waddington, F. W. K. Tam, H. T. Cook, and V. Cattell Arginase activity is modulated by IL-4 and HOArg in nephritic glomeruli and mesangial cells Am J Physiol Renal Physiol, March 1, 1998; 274(3): F473 - F480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-I Chang, J. C. Liao, and L. Kuo Arginase modulates nitric oxide production in activated macrophages Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H342 - H348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Shearer, C. F. Coulter, W. C. Engeland, R. A. Roth, and M. D. Caldwell Insulin is degraded extracellularly in wounds by insulin-degrading enzyme (EC 3.4.24.56) Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E657 - E664. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
